We are live on ! Find out more
SLDB icon

Solid Biosciences
SLDB

124 hedge funds and large institutions have $292M invested in Solid Biosciences in 2025 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 43 increasing their positions, 16 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

227% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 15

169% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 16

101% more capital invested

Capital invested by funds: $145M → $292M (+$146M)

38% more funds holding

Funds holding: 90 → 124 (+34)

10.83% more ownership

Funds ownership: 90.92% → 101.75% (+11%)

0% more call options, than puts

Call options by funds: $714K | Put options by funds: $714K

Holders
124
Holders Change
+34
Holders Change %
+37.78%
% of All Funds
1.66%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
49
Increased
43
Reduced
16
Closed
15
Calls
$714K
Puts
$714K
Net Calls
–
Net Calls Change
-$2.28M

Top Buyers

Rank Fund Capital Flow
1
CC
Commodore Capital
New York
+$24.9M
2
PA
Perceptive Advisors
New York
+$21.4M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$21.3M
4
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
+$16.6M
5
SL
Siren LLC
Connecticut
+$15.7M

Top Sellers

Rank Fund Capital Flow
1
VPC
Vestal Point Capital
New York
-$4.69M
2
JP Morgan Chase
JP Morgan Chase
New York
-$4.02M
3
LCM
Laurion Capital Management
New York
-$1.02M
4
Millennium Management
Millennium Management
New York
-$793K
5
N
Nuveen
North Carolina
-$661K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
26
Silverarc Capital Management
Massachusetts
$1.67M +$1.94M +452,239 New
State Street
27
State Street
Massachusetts
$1.61M +$17.6K +4,100 +0.9%
Morgan Stanley
28
Morgan Stanley
New York
$1.31M +$1.18M +275,739 +354%
Marshall Wace
29
Marshall Wace
United Kingdom
$1.24M +$663K +154,824 +85%
NCM
30
Nantahala Capital Management
Connecticut
$1.04M +$1.2M +281,368 New
Dimensional Fund Advisors
31
Dimensional Fund Advisors
Texas
$998K +$23.2K +5,412 +2%
IC
32
Ikarian Capital
Texas
$851K +$985K +230,000 New
Point72 Asset Management
33
Point72 Asset Management
Connecticut
$745K +$862K +201,419 New
SC
34
Stempoint Capital
New York
$733K +$848K +198,150 New
Susquehanna International Group
35
Susquehanna International Group
Pennsylvania
$732K +$620K +144,802 +273%
Goldman Sachs
36
Goldman Sachs
New York
$667K +$188K +43,910 +32%
Northern Trust
37
Northern Trust
Illinois
$658K +$37.7K +8,798 +5%
Renaissance Technologies
38
Renaissance Technologies
New York
$649K +$398K +92,907 +113%
TI
39
Trexquant Investment
Connecticut
$618K -$117K -27,250 -14%
RCAP
40
Resolute Capital Asset Partners
Colorado
$555K +$642K +150,000 New
SFI
41
Susquehanna Fundamental Investments
Pennsylvania
$524K +$606K +141,552 New
DMKJ
42
David M. Knott Jr
$488K +$565K +132,000 New
BC
43
Birchview Capital
Vermont
$476K +$551K +128,768 New
UBS Group
44
UBS Group
Switzerland
$424K +$86.6K +20,228 +21%
AQR Capital Management
45
AQR Capital Management
Connecticut
$418K +$484K +113,099 New
ACA
46
Apis Capital Advisors
New York
$407K +$471K +110,000 New
Squarepoint
47
Squarepoint
New York
$391K +$452K +105,682 New
LGM
48
Logos Global Management
California
$370K +$428K +100,000 New
BCM
49
Bridgeway Capital Management
Texas
$309K -$81.8K -19,100 -19%
JF
50
Jump Financial
Illinois
$282K +$327K +76,318 New
1
2
3 4 5

SLDB Hedge Fund Activity: Q1 2025 in Review

124 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in Solid Biosciences (SLDB) for Q1 2025, worth a combined $292M — up 101% from $145M a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new SLDB positions and 15 closed out — a net gain of 34 holders — while 43 added to existing stakes and 16 trimmed.

The largest buyer was Commodore Capital, opening a new position worth an estimated $24.9M. The largest seller was Vestal Point Capital, cutting an estimated $4.69M.

  • 124 institutional investors held Solid Biosciences (SLDB) as of Q1 2025, up from 90 in Q4 2024.
  • Funds reported $292M of Solid Biosciences stock for Q1 2025, up 101% quarter-over-quarter.
  • 49 funds opened new Solid Biosciences positions in Q1 2025 and 15 closed out, a net change of +34 holders.
  • The largest Solid Biosciences buyer in Q1 2025 was Commodore Capital, an estimated $24.9M added.
  • The largest Solid Biosciences seller in Q1 2025 was Vestal Point Capital, an estimated $4.69M sold.

Based on aggregated 13F filings for Q1 2025.